NULISA Solution

NULISA Solution

Extreme Sensitivity, Breaking Limits,Capturing Ultra-Low Abundance Key Proteins

As an official Alamar Certified Service Provider (CSP), Sequanta integrates the revolutionary NULISA™ platform into our clinical-grade proteomics ecosystem. By leveraging our CAP/CLIA/ISO certified laboratories and extensive experience with over 1,000 samples, we provide ultra-high sensitivity detection down to the fg/mL level. With a breakthrough 12-log dynamic range and advanced dual-capture noise reduction technology, Sequanta’s NULISA solution empowers researchers to unlock ultra-low abundance biomarkers with unprecedented precision, accelerating the journey from discovery to clinical translation.

Technical Principle: Based on NULISA (Nucleic Acid Ligation Immunosandwich Assay) technology combined with a dual-capture noise reduction mechanism (Dual Capture), achieving ultra-highsensitivity protein quantification.